Our investigations suggested that the Rad51 G135C polymorphism is a candidate for susceptibility to overall cancers, especially to breast cancer, and that the G172T polymorphism is significantly associated with decreased risk of head and neck cancers. Here, RAD51 is linked to breast carcinoma.